Moneyview IPO Day 1: GMP ₹0

Hello investors! We’re diving straight into the Moneyview IPO’s first day of subscription. As of the close of Day 1, the IPO hasn’t seen any significant traction across any investor category. The subscription figures are currently at zero across the board for Retail, NII, and QIB investors. This is a bit surprising, given the IPO opened today. Let’s break down what this initial status means and what the Grey Market Premium (GMP) is telling us.

Subscription Status

The subscription numbers for Moneyview’s IPO on Day 1 are remarkably flat. We’re seeing 0x subscription across all categories: Retail Individual Investors (RIIs), Non-Institutional Investors (NIIs), and Qualified Institutional Buyers (QIBs). This means not a single share has been subscribed for yet by any segment. Typically, you’d expect at least some initial interest, especially from retail investors, on the opening day. The absence of any subscriptions could indicate a few things. It might be that investors are waiting to see how the market reacts over the next few days, or perhaps they’re assessing the company’s fundamentals more closely before committing. For NIIs and QIBs, who often invest larger sums, a zero subscription on Day 1 isn’t necessarily a red flag yet, as they tend to apply towards the latter half of the subscription period. However, it’s certainly something to keep an eye on as the IPO progresses. The total subscription stands at 0x, reflecting this quiet start.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Moneyview IPO is ₹0. This is unchanged from yesterday’s GMP, which was also ₹0. A GMP of ₹0 suggests that the market sentiment is currently neutral, with no premium being bid for the shares in the unofficial market. This aligns with the subdued subscription activity we’re seeing on Day 1. When the GMP is at ₹0, it implies that the market expects the stock to list at its issue price of ₹34. This isn’t ideal for investors looking for an immediate listing gain, but it also doesn’t signal any immediate downside risk in the grey market. It’s worth remembering that GMP is an indicator of market sentiment and can fluctuate.

Should You Apply?

So, the big question: should you apply for the Moneyview IPO based on Day 1’s performance? It’s a bit early to make a definitive call. The lack of subscription on Day 1 and a ₹0 GMP mean there’s no immediate buzz or strong indication of listing gains. However, the IPO period is from September 24, 2026, to September 28, 2026, giving investors ample time to evaluate. The expected listing price is ₹34, which is also the issue price. This suggests the company and its advisors are aiming for a steady debut rather than a speculative one.

If you’re an investor who believes in the long-term potential of Moneyview and its business model, the current lack of oversubscription might even present an opportunity to get in at the issue price without the pressure of a highly competitive subscription. However, if your primary goal is quick listing gains, the current GMP and subscription data might make you hesitant. As per SEBI advisor guidelines, it’s always prudent to conduct thorough due diligence on the company’s financials, management, and future prospects before investing. Don’t just rely on subscription numbers or GMP alone.

You can view the full Moneyview IPO details and stay updated here: View Full Moneyview IPO Details. We’ll be back with more updates as the subscription progresses.